Posted on

gastroparesis cbd oil

Aside from managing severe symptoms of gastroparesis, cannabinoids have also proved to be very effective in managing anxiety and depression. Since CBD works directly together with your body’s ECS receptors, it has a direct effect on your mood, appetite, and tolerance to pain, thus improving your quality of life.

If you always have difficulties emptying your stomach naturally, then you are probably suffering from gastroparesis–partial paralysis of the stomach. This is a serious medical condition that prevents the stomach from emptying itself of food naturally. Gastroparesis is normally characterized by nausea, an unsettled stomach, heartburn, and always having a full stomach.

Cannabinoid is a natural compound found in the Cannabis sativa plant, which is known for its many medicinal properties. Of the hundreds of different natural compounds found in this plant, only 66 are classified as cannabinoids.

Picking the Most Effective Delivery Method

Although there is no definite cure for this medical condition, there are several medications and surgical remedies that have proved to be effective in mitigating symptoms. Among the most commonly used medicines is a cannabinoid (CBD). However, many concerns have been raised over the efficacy of CBD in treating gastroparesis. So, in this article, we will answer this question: Does CBD help with gastroparesis? In short, CBD is not a conclusive sure but can help some people manage their symptoms.

In the study, 24 patients with gastroparesis symptoms were prescribed medical marijuana for 60 days. After the trial period, all patients reported a statistically noteworthy improvement in their symptoms, including abdominal pain. This led the NCBI to conclude that cannabinoids can dramatically improve severe symptoms of gastroparesis.

While there are many CBD strains available for medical use, not all of them can effectively manage the various symptoms of gastroparesis. Therefore, it is important to consult your doctor for advice on the best CBD and gastroparesis strains. Make sure you choose a strain that is suitable for most symptoms.

Our bodies have natural cannabinoids that keep us stable internally. So, CBD medications supply our bodies with additional cannabinoids for improved body homeostasis.

We are all individuals with a unique endocannabinoid system. For many of us battling with chronic pain and long-term incurable illnesses, our endocannabinoid system is not balanced. With cannabis therapy, along with diet and exercise, we can have a better quality of life. Know that you do have other options when pharmacy medication does not help. Cannabis has so much potential.

By then, it had been almost a year before I had finally been able to find someone even willing to entertain the idea of prescribing me cannabis. I self-referred myself to Lockwood Clinic to Toronto (a full 8-hour drive from home). My youngest son escorted me via airplane. I was too weak and ill to drive, especially on my own. I was there for 3 days.

I was never again hospitalized overnight due to my severe nausea and vomiting in the last 3 years. With all my experience, I also have PTSD when it comes to hospital because of no one listening to my symptoms for so long and believing it was going to get better with all the meds trials.

Were you worried about side effects? Now that you have been on it, have you experienced any negative side effects?

During my flare ups, I keep myself hydrated with homemade beef bone broth and smoothies. It will be 4 years on April 8, 2015 that I started my healing journey with medicinal cannabis, and it was the best decision I ever made to help my illnesses. I was able to gain back 25 pounds and maintain it.

I ask her for research and proof. I give her all the information I had received from my cannabis sup-port group. We both learned together and am thankful that she did listened to my VOICE. I was able to keep my fluids down and I was able to deal with this disease better mentally and physically. My dietitian found another doctor for me in 2016 out of town. I started to make homemade beef bone broth, and homemade smoothies. My new family doctor was a good compassionate doctor and de-cided to go ahead with the Natural Desiccated Thyroid for my thyroid, he had never prescribed it but was willing to learn with me. I unfortunately loss him because he had to relocate for personally reason. I am now under a care of RPN and she is also learning about my new thyroid meds.

I approached my family doctor about medicinal cannabis shortly after I had made this internal decision. He, unfortunately, wanted nothing to do with prescribing me this new therapy option and had no support from him. Another road block!

I started to educate myself more on the internet about GP and join a wonderful gastroparesis support group on facebook . Some of the members discuss about cannabis therapy and how much it helped ease the nausea and appetite.

The effects of cannabinoids on gastroparesis symptoms were prospectively assessed in 24 patients. Patients were selected based on refractory symptoms from a single gastroenterology practice associated with a tertiary care medical center. Patients included in the study first required a confirmed diagnosis of gastroparesis via a nuclear gastric emptying study that displayed delayed gastric emptying, and esophagogastroduodenoscopies (EGD) that ruled out mechanical obstruction. Only patients with symptoms that were refractory to standard therapies for gastroparesis were included (this included dietary modification, medications (prokinetics, antiemetics, and neuromodulators), endoscopic therapy (e.g. botulinum toxin injections), and some patients had implantable gastric stimulators and/or surgical pyloroplasty).

We performed bivariate analysis with Pearson’s chi-squared test to compare the demographic differences in study groups. To compare the differences in the composite scores (pre and post-treatment) for each group, we utilized a paired-sample t-test and reported 95% confidence intervals for mean score differences. We used an unpaired t-test to analyze the differences in treatment outcomes between the study groups. We reported two-sided p-values and a p-value less than 0.05 was considered statistically significant. All statistical analyses were performed using the SPSS Statistical software v25.0 (IBM Corp, Chicago, Illinois).

The pathophysiology resulting in gastroparesis symptoms is not fully understood, although neuropathy likely plays a large role in its pathogenesis. The impairment of normal phasic motor activity in the distal stomach produces the clinical manifestations related to delayed gastric emptying. The frequency and direction of the phasic motor activity is regulated by the gastric slow wave, a rhythmic electrical oscillation, which is generated by the interstitial cells of Cajal in the proximal gastric body – this area thus is known as the “pacemaker” zone of the stomach [10]. Treatments for gastroparesis often focus on improving gastric motility, though data regarding the correlation between the degree of delayed gastric emptying and symptom manifestations is variable [11]. Other treatments in gastroparesis aim to control its associated symptoms and include antiemetics and neuromodulators. The latter group of medications has often been used to treat abdominal pain specifically, despite a lack of efficacy seen in clinical trials [12].

Table 1

The socioeconomic impact and detrimental effect on the quality of life resulting from gastroparesis is significant and is increasing in recent years. Over 10% of patients reported being disabled due to their condition, while many other gastroparetics report missing significant work days and income [4-6]. Hospitalizations for gastroparesis increased by >150% over 1995-2004 and >300% over 1997-2013, with hospitalizations for gastroparesis resulting in extended lengths of stay as compared to hospitalizations for other upper gastrointestinal (GI) disorders [7-8]. Although the exact prevalence of gastroparesis in the United States is unknown, it seems to be an under-diagnosed and thus under-treated disorder [9].

Cannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), are becoming increasingly studied and used for medicinal purposes. Dronabinol, a synthetic THC analog, is used for nausea, vomiting, and anorexia in human immunodeficiency virus (HIV) and cancer though it has been used for symptom management in other conditions [13-14]. Medical marijuana in New York is permitted to treat neuropathy with severe nausea or severe pain [15]. Given the treatment indications for these cannabinoids, it is reasonable that they can serve a beneficial role in the management of gastroparesis. Newer, and more effective, treatment options for gastroparesis are needed and cannabinoids are a promising option. The study aimed at evaluating the effects of cannabinoids on refractory gastroparesis symptoms.

Patients were prescribed either dronabinol, medical cannabis, or both, for symptom management. Those who received both treatments had them prescribed sequentially (dronabinol then marijuana) if dronabinol did not adequately relieve symptoms. Marijuana was prescribed as needed at varying THC:CBD ratios (at the discretion of the cannabis dispensary) and taken via vaporized inhalation or sublingual drops. The dosage of dronabinol ranged from 2-10 mg twice daily to four times daily. Patients completed a GCSI form, a validated symptom index for gastroparesis, before and after treatment (Table ​ (Table1 1 ).

A significant improvement in the GCSI total symptom composite score was seen with either cannabinoid treatment (mean score difference of 12.8, 95% confidence interval 10.4-15.2; p-value < 0. 001). Patients prescribed marijuana experienced a statistically significant improvement in every GCSI symptom subgroup. Significant improvement in abdominal pain score was also seen with either cannabinoid treatment (mean score difference of 1.6; p-value <0.001).